Healthcare Dec 31, 2021 05:52 PM (GMT+8) · EqualOcean
On December 31st, the latest announcement of the official website of the China National Drug Administration, the listing application of proline Heng Ge Jing Jing, a SGLT-2 inhibitor of Hang Rui medicine, has been approved for improving glycemic control in adults with type 2 diabetes. Sglt-2 inhibitor reduces blood glucose by reducing renal reabsorption of glucose. It is a kind of non insulin dependent hypoglycemic drugs, and there is basically no risk of hypoglycemia.